Level A· Stronger Clinical EvidenceSystematic ReviewEurope PMCOpen access

Adipocyte-Derived Stem Cells in the Treatment of Spinal Cord Injuries in Animal Models: A Systematic Review

Jamil F., Ahmed T., Iqbal H., Vogt A., Khan W.

Systematic Review on Spinal Cord Injury, published in Int J Mol Sci (2025) — summary generated from the PubMed abstract.

Open my reading list
Level A· Stronger Clinical EvidenceEvidence level of this study

Relatively higher-quality human studies compared with other topics in this database, e.g. multiple RCTs or systematic reviews. This does not mean it is standard or approved care.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Systematic Review
Journal
Int J Mol Sci (2025)
Reported sample size
—
Source database
Europe PMC
PMID
41096598
PMCID
PMC12524765
DOI
10.3390/ijms26199330
Citations
1

Abstract (original English)

Spinal cord injury (SCI) represents a burdensome and currently incurable condition which affects over 20 million patients globally. Adipocyte-derived mesenchymal stem cell (ADSC) therapy may constitute a valuable strategy in treating this condition, owing to their unique cellular characteristics and beneficial effects on functional recovery. This PRISMA (Preferred Reporting Items for Systematic Reviews) review aims to assess whether ADSC therapy is a viable strategy for treating SCI in animal models. We identified a total of 1561 studies after performing a search of four databases, including PubMed, Web of Science, Scopus and Medline. After applying inclusion and exclusion criteria, we identified a total of 16 articles that were reviewed, assessed and reported in our study. General characteristics of these studies, results of stem cell characterisation, SCI induction protocols, locomotor recovery and bladder function following SCI, were investigated as part of our analysis. Fifteen studies suggested that ADSC therapy has a beneficial effect on motor recovery following SCI. The evidence base regarding adjuvant therapies was, however, variable. Further investigations into the mechanisms that underly recovery following ADSC therapy, and potential adjuvants which could enhance these effects, should follow the outcomes of this systematic review. In turn, this would help expand the t

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.

Evidence level

Relatively higher-quality human studies compared with other topics in this database, e.g. multiple RCTs or systematic reviews. This does not mean it is standard or approved care.

How we grade evidence
AdipocytesMesenchymal Stem CellsAnimalsHumansSpinal Cord InjuriesDisease Models, AnimalMesenchymal Stem Cell TransplantationRecovery of Function

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research